Long-term sustained disease control in patients with mantle cell lymphoma with or without active disease after treatment with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning

Author： Vaughn Jennifer E.   Sorror Mohamed L.   Storer Barry E.   Chauncey Thomas R.   Pulsipher Michael A.   Maziarz Richard T.   Maris Michael B.   Hari Parameswaran   Laport Ginna G.   Franke Georg N.   Agura Edward D.   Langston Amelia A.   Rezvani Andrew R.   Storb Rainer   Sandmaier Brenda M.   Maloney David G.  

Publisher： Blackwell Publishing

E-ISSN： 1097-0142|121|20|3709-3716

ISSN： 0008-543X

Source： Cancer, Vol.121, Iss.20, 2015-10, pp. : 3709-3716

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oral beclomethasone dipropionate: a topically active corticosteroid for the treatment of gastrointestinal graft-versus-host disease following allogeneic hematopoietic cell transplantation

By McDonald George B  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 10, 2007-10 ,pp. : 1709-1724

Informa Healthcare

Access to resources Recommend Favorite

Delayed platelet recovery after allogeneic hematopoietic stem cell transplantation: Association with chronic graft‐versus‐host disease and survival outcome

By  

Hematological Oncology (Electronic), Vol. 36, Iss. 1, 2018-02 ,pp. : 276-284

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long-term survival of high-risk melanoma patients immunized with a Hyper-IL-6-modified allogeneic whole-cell vaccine after complete resection

By Mackiewicz Andrzej   Mackiewicz Jacek   Wysocki Piotr J.   Wiznerowicz Maciej   Kapcinska Malgorzata   Laciak Maria   Rose-John Stefan   Izycki Dariusz   Burzykowski Tomasz   Karczewska-Dzionk Aldona  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 6, 2012-06 ,pp. : 773-783

Informa Healthcare

Access to resources Recommend Favorite

Targeted Anti-leukemic Therapy as Disease-stabilizing Treatment for Acute Myeloid Leukemia Relapse after Allogeneic Stem Cell Transplantation: Will it be Possible to Combine these Strategies with Retransplantation or Donor Lymphocyte Infusions?

By  

Current Cancer Drug Targets, Vol. 13, Iss. 1, 2013-01 ,pp. : 30-47

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging drugs for prevention of graft failure after allogeneic hematopoietic stem cell transplantation

By Servais Sophie   Beguin Yves   Baron Frédéric  

Expert Opinion on Emerging Drugs, Vol. 18, Iss. 2, 2013-06 ,pp. : 173-192

Informa Healthcare

Access to resources Recommend Favorite